"According to the latest report published by Data Bridge Market Research, the Mitogen-Activated Protein Kinase (MAPK) Inhibitors Therapeutics Market  The expected CAGR of mitogen-activated protein kinase (MAPK) inhibitors therapeutics market is tend to be around 6.60% in the mentioned forecast period. The market is valued at USD 61.4 billion in 2022, and it would grow upto USD...